InVivo Therapeutics Holdings Corp (NVIVQ)

[pistol1p]

Volume picking up since the announcement (October 15th) of the 1st patient in the trial: Averaging 1.5 million shares traded.

As long as the news continues to be positive and the trial continues, we should see the pps appreciate.

I think the current shareholders aren't necessarily eager to sell their shares, and are willing to wait for a bigger payoff as the trial progresses. The Buy/Sell ratio was about 7 to 2 today.

Of course, Frank Reynolds, may still be selling, but if the volume stays up, hopefully he either will liquidate his remaining shares or decide to hold his shares as the pps moves up.

I am definitely going to see how this 1st human trial plays out, before I make any decisions about selling my shares.